Related Experiment Video
Updated: Jun 6, 2026
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Performance characteristics of a new Immulite(®) 2000 system erythropoietin assay
William E Owen1, William L Roberts
1ARUP Institute for Clinical and Experimental Pathology(®), Salt Lake City, UT, USA.
Background:
Serum erythropoietin (EPO) measurements are useful for diagnostic evaluations of anemia, polycythemia, and other erythroid disorders.
Methods:
We evaluated a new formulation of the chemiluminescent immunoassay for EPO on the Immulite 2000 analyzer (Siemens Healthcare Diagnostics) for limit of blank (LoB), imprecision, linearity, interference, comparison to another commercially available assay, reference interval, and cross-reactivity with 2 recombinant EPO preparations.
Results:
The LoB was 0.23IU/l. Total imprecision ranged from 4.2 to 12.1%. The assay was linear from 0 to 678IU/l. Hemoglobin caused negative interference at concentrations >17.4g/l. Deming regression from the method comparison study gave a slope of 1.00±0.04, an intercept of 3.9±12.7, and a S(y/x) of 44.9 (r=0.98). The non-parametric reference interval was 3.3 to 23.4IU/l. Epoetin alfa at a1:2000 dilution gave mean results of 541IU/l and 650IU/l for Immulite 2000 and Access 2, respectively. Darbopoetin alfa at a 1:2000 dilution gave mean results of 337IU/l and 579IU/l for the Immulite 2000 and Access 2, respectively, indicating the 2 assays have substantially different cross-reactivities with recombinant EPO preparations.
Conclusions:
The new Immulite 2000 EPO assay shows acceptable performance and is suitable for routine clinical use.
